Smoking interacts with sleep apnea to increase cardiovascular risk

Sleep Medicine

Volumn 9, Issue 3, 2008, Pages 247-253

  Lavie, Lena ^a   Lavie, Peretz ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Inflammation; Oxidative stress; Sleep apnea; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ARYLDIALKYLPHOSPHATASE 1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CERULOPLASMIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SLEEP APNEA SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CERULOPLASMIN; CHOLESTEROL, HDL; COMORBIDITY; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HAPTOGLOBINS; HUMANS; INFLAMMATION MEDIATORS; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN; POLYSOMNOGRAPHY; REFERENCE VALUES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SMOKING; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 40749125338     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2007.03.018     Document Type: Article

References (40)

1. Malhotra A., and White D.P. Obstructive sleep apnoea. Lancet 360 (2002) 237-245
2. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 7 (2003) 35-51
3. Lavie L., Vishnevsky A., and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27 (2004) 123-128
4. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162 2 Pt 1 (2000) 566-570
5. Yamauchi M., Nakano H., Maekawa J., et al. Oxidative stress in obstructive sleep apnea. Chest 127 (2005) 1674-1679
6. Dyugovskaya L., Lavie P., and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165 (2002) 934-939
7. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134
8. Dyugovskaya L., Lavie P., and Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168 (2003) 242-249
9. Dyugovskaya L., Lavie P., Hirsh M., and Lavie L. Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25 (2005) 820-828
10. Lavie L., Hefetz A., Luboshitzky R., and Lavie P. Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatement. J Mol Neurosci 21 (2003) 57-63
11. Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., and Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172 (2005) 613-618
12. Ip M.S., Tse H.F., Lam B., Tsang K.W., and Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. Am J respir Crit Care Med 169 (2004) 348-353
13. Itzhaki S., Lavie L., Pillar G., Tal G., and Lavie P. Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep 28 (2005) 594-600
14. Morrow J.D., Frei B., Longmire A.W., et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 332 (1995) 1198-1203
15. Bermudez E.A., Rifai N., Buring J.E., Manson J.E., and Ridker P.M. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89 (2002) 1117-1119
16. McVeigh G.E., Lemay L., Morgan D., and Cohn J.N. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 78 (1996) 668-672
17. Ridker P.M., and Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 109 (2004) 1955-1959
18. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
19. Sadrzadeh S.M., and Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 121 Suppl (2004) S97-S104
20. Wassell J. Haptoglobin: function and polymorphism. Clin Lab 46 (2000) 547-552
21. Hellman N.E., and Gitlin J.D. Ceruloplasmin metabolism and function. Ann Rev Nutr 22 (2002) 439-458
22. Fox P.L., Mazumder B., Ehrenwald E., and Mukhopadhyay C.K. Ceruloplasmin and cardiovascular disease. Free Radic Biol Med 28 (2000) 1735-1744
23. Galdston M., Feldman J.G., Levytska V., and Magnusson B. Antioxidant activity of serum ceruloplasmin and transferrin available iron-binding capacity in smokers and nonsmokers. Am Rev Respir Dis. 135 (1987) 783-787
24. Lind P., Engstrom G., Stavenow L., Janzon L., Lindgarde F., and Hedblad B. Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins. Arterioscler Thromb Vasc Biol. 24 (2004) 577-582
25. Bazzano L.A., He J., Muntner P., Vupputuri S., and Whelton P.K. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 138 (2003) 891-897
26. Ohsawa M., Okayama A., Nakamura M., et al. CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers. Prev Med. 41 (2005) 651-656
27. Wolf G.T., Chretien P.B., Weiss J.F., Edwards B.K., and Spiegel H.E. Effects of smoking and age on serum levels of immune reactive proteins. Otolaryngol Head Neck Surg. 90 3 Pt 1 (1982) 319-326
28. Zoppini G., Faccini G., Muggeo M., Zenari L., Falezza G., and Targher G. Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes. J Clin Endocrinol Metab. 86 (2001) 3805-3808
29. Guilleminault C., Kirisoglu C., and Ohayon M.M. C-reactive protein and sleep-disordered breathing. Sleep 27 (2004) 1507-1511
30. Akashiba T., Akahoshi T., Kawahara S., Majima T., and Horie T. Effects of long-term nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome. Intern Med 44 (2005) 899-900
31. Lavie L., Vishnevsky A., and Lavie P. Oxidative stress and systemic inflammation in patients with sleep apnea: role of obesity. Sleep and Biol Rhythms 5 (2007) 99-109
32. Connelly P.W., Petrasovits A., Stachenko S., MacLean D.R., Little J.A., and Chockalingam A. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group. Can J Cardiol. 15 (1999) 428-433
33. Blann A.D., Seigneur M., Steiner M., Miller J.P., and McCollum C.N. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost 79 (1998) 1080-1085
34. Takeuchi N., Kawamura T., Kanai A., et al. The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with Type 2 diabetes mellitus. Diabet Med 19 (2002) 57-64
35. Adams M.R., Jessup W., and Celermajer D.S. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol. 29 (1997) 491-497
36. Weber C., Erl C., Weber K., and Weber P.C. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 93 (1996) 1488-1492
37. Higman D.J., Strachan A.M., and Powell J.T. Reversibility of smoking-induced endothelial dysfunction. Br J Surg. 81 (1994) 977-978
38. Bridges A.B., Scott N.A., Parry G.J., and Belch J.J. Age, sex, cigarette smoking and indices of free radical activity in healthy humans. Eur J Med. 2 (1993) 205-208
39. Pech-Amsellem M.A., Myara I., Storogenko M., Demuth K., Proust A., and Moatti N. Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis. Cardiovasc Res. 31 (1996) 975-983
40. Solak Z.A., Kabaroglu C., Cok G., et al. Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people. Clin Exp Med 5 (2005) 99-105